The severity of pandemic H1N1 influenza in the United States, April – July 2009

Background Accurate measures of the severity of pandemic influenza A/H1N1 (pH1N1) are needed to assess the likely impact of an anticipated resurgence in the autumn in the Northern Hemisphere. Severity has been difficult to measure because jurisdictions with large numbers of deaths and other severe outcomes have had too many cases to assess the total number with confidence. Also, detection of severe cases may be more likely. Methods and Findings We used complementary data from two US cities: Milwaukee attempted to identify cases of medically attended infection whether or not they required hospitalization, while New York City focused on the identification of hospitalizations, intensive care admission or mechanical ventilation (hereafter, ICU), and deaths. New York data were used to estimate numerators for ICU and death, and two sources of data: medically attended cases in Milwaukee or self-reported influenza-like illness in New York, were used to estimate ratios of symptomatic cases:hospitalizations. Combining these data with estimates of the fraction detected for each level of severity, we estimated the proportion of symptomatic cases that died (symptomatic case-fatality ratio, sCFR), required ICU (sCIR), and required hospitalization (sCHR), overall and by age category. Evidence, prior information and associated uncertainty were analyzed in a Bayesian evidence synthesis framework. Using medically attended cases and estimates of the proportion of symptomatic cases medically attended, we estimated sCFR of 0.048% (95% credible interval, CI 0.026%-0.096%), sCIR of 0.239% (0.134%-0.458%), and sCHR of 1.44% (0.83%-2.64%). Using self-reported ILI, we obtained estimates approximately 7-9x lower. sCFR and sCIR appear to be highest in persons 18 and older, and lowest in children 5-17. sCHR appears to be lowest in persons 5-17; our data were too sparse to allow us to determine the group in which it was the highest. Conclusions These estimates suggest that an autumn-winter pandemic wave of pH1N1 with comparable severity per case could lead to a number of deaths in the range from considerably below that associated with seasonal influenza to slightly higher, but with greatest impact in young children and non-elderly adults. These estimates of impact depend on assumptions about total incidence of infection and would be larger if incidence of symptomatic infection were higher or shifted toward adults, if viral virulence increased, or if suboptimal treatment resulted from stress on the health care system; numbers would decrease if the proportion infected or symptomatic were lower.

[1]  Matthew Biggerstaff,et al.  Estimating the burden of 2009 pandemic influenza A (H1N1) in the United States (April 2009-April 2010). , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  Marc Lipsitch,et al.  Estimates of the Prevalence of Pandemic (H1N1) 2009, United States, April–July 2009 , 2009, Emerging infectious diseases.

[3]  Benjamin J Cowling,et al.  How to maintain surveillance for novel influenza A H1N1 when there are too many cases to count , 2009, The Lancet.

[4]  M. Pagano,et al.  Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA , 2009, Influenza and other respiratory viruses.

[5]  Hiroshi Nishiura,et al.  Early Epidemiological Assessment of the Virulence of Emerging Infectious Diseases: A Case Study of an Influenza Pandemic , 2009, PloS one.

[6]  K Mason,et al.  Pandemic influenza A(H1N1)v in New Zealand: the experience from April to August 2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  Nathaniel Hupert,et al.  Initial human transmission dynamics of the pandemic (H1N1) 2009 virus in North America , 2009, Influenza and other respiratory viruses.

[8]  Simon Cauchemez,et al.  Assessing the severity of the novel influenza A/H1N1 pandemic , 2009, BMJ : British Medical Journal.

[9]  N Wilson,et al.  The emerging influenza pandemic: estimating the case fatality ratio. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[10]  E. Lyons,et al.  Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings , 2009, Science.

[11]  M. Safan,et al.  Transmission potential of the new influenza A(H1N1) virus and its age-specificity in Japan. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[12]  J. Desenclos,et al.  A preliminary estimation of the reproduction ratio for new influenza A(H1N1) from the outbreak in Mexico, March-April 2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[13]  Ramakrishna Prasad,et al.  Low sensitivity of rapid diagnostic test for influenza. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Lynnette Brammer,et al.  Estimates of US influenza‐associated deaths made using four different methods , 2009, Influenza and other respiratory viruses.

[15]  M. Shaw,et al.  Evaluation of rapid influenza diagnostic tests for detection of novel influenza A (H1N1) Virus - United States, 2009. , 2009, MMWR. Morbidity and mortality weekly report.

[16]  David J. Spiegelhalter,et al.  Conflicting evidence in a Bayesian synthesis of surveillance data to estimate human immunodeficiency virus prevalence , 2008 .

[17]  Cecile Viboud,et al.  Prioritization of influenza pandemic vaccination to minimize years of life lost. , 2008, The Journal of infectious diseases.

[18]  Catherine H Mercer,et al.  Estimates of human immunodeficiency virus prevalence and proportion diagnosed based on Bayesian multiparameter synthesis of surveillance data , 2008 .

[19]  C. Macken,et al.  Modeling targeted layered containment of an influenza pandemic in the United States , 2008, Proceedings of the National Academy of Sciences.

[20]  Cécile Viboud,et al.  Epidemiologic characterization of the 1918 influenza pandemic summer wave in Copenhagen: implications for pandemic control strategies. , 2008, The Journal of infectious diseases.

[21]  D. Cummings,et al.  Strategies for mitigating an influenza pandemic , 2006, Nature.

[22]  Ken P Kleinman,et al.  Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system. , 2005, American journal of epidemiology.

[23]  J. Robins,et al.  Transmissibility of 1918 pandemic influenza , 2004, Nature.

[24]  Kristina B Metzger,et al.  How many illnesses does one emergency department visit represent? Using a population-based telephone survey to estimate the syndromic multiplier. , 2004, MMWR supplements.

[25]  Keiji Fukuda,et al.  Influenza-associated hospitalizations in the United States. , 2004, JAMA.

[26]  Mark A. Miller,et al.  Influenza and the winter increase in mortality in the United States, 1959-1999. , 2004, American journal of epidemiology.

[27]  Keiji Fukuda,et al.  Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.

[28]  L. Simonsen,et al.  Pandemic versus epidemic influenza mortality: a pattern of changing age distribution. , 1998, The Journal of infectious diseases.

[29]  M. Cooney,et al.  Longitudinal studies of types A and B influenza among Seattle schoolchildren and families, 1968-74. , 1976, The Journal of infectious diseases.

[30]  R. Bailey,et al.  Hong Kong influenza: the epidemiologic features of a high school family study analyzed and compared with a similar study during the 1957 Asian influenza epidemic. , 1970, American journal of epidemiology.

[31]  W. S. Jordan,et al.  A study of illness in a group of Cleveland families. XVII. The occurrence of Asian influenza. , 1958, American journal of hygiene.

[32]  R. Sutton,et al.  Serological studies with Asian strain of influenza A. , 1958, Lancet.